Cancer Pain 101: A Digital, Asynchronous Intervention of Pain Management in Advanced Cancer

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Alabama at Birmingham

About this trial

This is a Stage 1 study of a behavioral intervention, which means that a new intervention is being pilot tested to understand whether it is acceptable and feasible for people with advanced cancer to use. The purpose of this study is to evaluate whether a series of 3 10-minute videos may help improve prescription opioid pain management and opioid stigma for people living with advanced cancer. Approximately 45 participants will take part in this study at the University of Alabama at Birmingham. People who choose to participate in this study will complete a series of baseline questionnaires, and then will be randomized to one of two groups: 1) the group that gets the video intervention, or 2) the group that gets a written handout with information about cancer pain. About 4 weeks later, all participants will also be asked to fill out another series of questionnaires.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

age ≥ 18 years old

speaks English

current, advanced solid tumor cancer diagnosis (stage III or IV)

endorses cancer-related pain (e.g,. pain, that began, worsened, and/or changed during cancer)

Disqualifiers

observable psychiatric disorders that would interfere with study participation (e.g., dementia, psychosis)

inability to speak and read English

inability to provide informed consent

prior participation in aspects of this study (i.e., K08 Aims 1 and 2)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Cancer Pain 101

    Behavioral

    The study intervention is Cancer Pain 101. Cancer Pain 101 is a 3-part educational video series, designed to be delivered asynchronously. Each video is approximately 10 minutes long and is narrated by a multidisciplinary team, including a psychologist, oncologist, palliative care clinician, and pharmacist.

Treatment groups

45 Participants
are divided into 2 treatment groups
Group A: InterventionExperimental treatment 1 intervention
Group B: Educational ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Participants who watch at least one video

Count participants who watch at least one video

Time frame
4 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Alabama at Birmingham

Lead sponsor

National Cancer Institute (NCI)

Collaborator

This trial is not recruiting at the moment. You can still explore other options: